Search clinical trials for: Alcoholic beverage

Total 1898 results

Shanghai Mental Health Center
University of Massachusetts, Worcester

Completed

Naltrexone and Bupropion Combination on Obese,Smoking Patients With Schizophrenia

Schizophrenia | Obese | Cigarette-smoking
Medical University of South Carolina
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Completed

An Exploratory Study of Naltrexone Plus Aripiprazole for Alcohol Dependence (NALAPZ)

Alcohol Dependence

United States
Orexigen Therapeutics, Inc

Terminated

Naltrexone/Bupropion Cardiovascular Outcomes Study

Cardiovascular Diseases | Obesity

United States
Orexigen Therapeutics, Inc

Completed

Study to Evaluate the Effect of Naltrexone and Bupropion Combination on the Pharmacokinetics of Metformin in Healthy Participants

Healthy Subjects
Hospital General de Mexico

Completed

Metadoxine as a Therapy for Severe Alcoholic Hepatitis

Severe Alcoholic Hepatitis

Mexico
Medical University of South Carolina
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Completed

Effectiveness of Naltrexone and/or Ondansetron to Reduce Craving for Alcohol and Drinking

Alcohol Dependence

United States
Yale University
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Recruiting

Pharmacological and Behavioral Treatment After Bariatric Surgery

Obesity

United States
Zuyderland Medisch Centrum
Nederlandse Obesitas Kliniek

Recruiting

Use of Mysimba in Patients With Weight Regain After Bariatric Surgery

Obesity, Morbid | Bariatric Surgery Candidate | Medication Persistence

Netherlands
Walter Ling
National Institute on Drug Abuse (NIDA); The Emmes Company, LLC

Completed

Accelerated Development of Additive Pharmacotherapy Treatment for Methamphetamine Use Disorder (ADAPT)

Methamphetamine Use Disorder

United States
Yale University

Completed

Treatment of Binge Eating Disorder in Obesity: Naltrexone/ Bupropion Combination Versus Placebo

Binge Eating Disorder

United States
Massachusetts General Hospital
National Alliance for Research on Schizophrenia and Depression

Completed

Acamprosate Added to Escitalopram and Behavioral Treatment for Comorbid Depression and Alcoholism

Alcohol Dependence | Major Depressive Disorder | Alcohol Abuse

United States
Columbia University
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Recruiting

Weight Loss Study: Genetics and Response to Naltrexone/Bupropion

Obesity

United States
Tasly GeneNet Pharmaceuticals Co., Ltd

Recruiting

A Study to Assess the Efficacy and Safety of PXT3003 in Charcot-Marie-Tooth Type 1A

Charcot-Marie-Tooth Type 1A

China
Yale University
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

Behavioral and Pharmacologic Treatment of Binge Eating and Obesity: Maintenance Therapy

Obesity | Binge-Eating Disorder

United States
The Scripps Research Institute
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Completed

Tobacco Dependence in Alcoholism Treatment (Nicotine Patch/Naltrexone)

Smoking | Alcoholism

United States
Alkermes, Inc.

Completed

ALK21-004: Single-dose Opiate Challenge of Medisorb® Naltrexone (VIVITROL®) in Adults Who Use Opioids

Opiate Dependence
VA Office of Research and Development

Completed

Ketamine for the Rapid Treatment of Major Depressive Disorder and Alcohol Use Disorder

Major Depressive Disorder | Alcohol Use Disorder

United States
Takeda

Withdrawn

Efficacy of Naltrexone HCl/Bupropion HCl Extended Release Versus Placebo for Treatment of Weight Regain in Participants Post Bariatric Surgery

Weight Regain Post Bariatric Surgery

United States
Vilnius University

Completed

The Comparison of Stress Response to Rapid Opioid Detoxification Applying Different Methods of Opioid Antagonism

Opiate Addiction

Lithuania
Currax Pharmaceuticals

Recruiting

Effect of Naltrexone Hydrochloride ER and Bupropion Hydrochloride ER Combination (Contrave®/Mysimba®) on Major Adverse Cardiovascular Events (MACE) (INFORMUS)

Obesity

United States
Yale University
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Recruiting

Pharmacological and Behavioral Treatment After Bariatric Surgery: Acute (Stage 1)

Loss-of-control Eating | Obesity/Overweight

United States
University of Florida
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Recruiting

ANCHORS Alcohol & Sexual Health Study: UH3 Project

Substance Use | Alcohol Use, Unspecified | Sex Behavior

United States
Yale University
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Enrolling by invitation

Pharmacological and Behavioral Treatments After Bariatric Surgery: Maintenance Treatment (Stage 2a)

Obesity/Overweight | Loss-of-Control Eating

United States
National Institute on Drug Abuse (NIDA)

Completed

Phase 1 Naltrexone-Bupropion-Methamphetamine Interaction Study

Methamphetamine Dependence

United States
Forest Laboratories

Completed

Effects of Cariprazine on Cardiac Repolarization in Patients With Schizophrenia

Schizophrenia

United States
Yale University
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Active, not recruiting

Behavioral and Pharmacologic Treatment of Binge Eating and Obesity: Acute Treatment

Obesity | Binge-eating Disorder

United States
Orexigen Therapeutics, Inc

Completed

A Study of Naltrexone SR/ Bupropion SR in Overweight or Obese Subjects With Major Depression

Depression

United States
University of Pennsylvania

Completed

Combining Pregabalin (LYRICA®) With Lofexidine (LUCEMYRATM) to Treat OPIOID Withdrawal (PGB-LOF)

Opioid Withdrawal

United States
Chen Ying

Enrolling by invitation

Efficacy of Anisodamine Hydrobromide Combined With Low-molecular-weight Heparin in the Treatment of Patients With Sepsis

Sepsis

China
Augusta University

Active, not recruiting

[COVID-19] Reduction of Sars-CoV-2 Oral Viral Load With Prophylactic Mouth Rinse

Covid19

United States
Bausch Health Americas, Inc.

Completed

Effects of MNTX on CYP450 2D6 in Metabolizers of Dextromethorphan

Healthy Adults

United States
Orexigen Therapeutics, Inc

Completed

A Safety and Efficacy Study of Naltrexone SR/Bupropion SR in Overweight and Obese Subjects

Obesity | Overweight

United States
Orexigen Therapeutics, Inc

Completed

A Study of Naltrexone SR/ Bupropion SR in Overweight and Obese Subjects Who Are Nicotine-Dependent

Obesity | Overweight | Nicotine Dependence

United States
Ensysce Biosciences
National Institute on Drug Abuse (NIDA); Quotient Sciences

Completed

Pharmacokinetics of Oxycodone and PF614 Co-Administered With Nafamostat (MPAR-101)

Pharmacokinetics

United States
University Medicine Greifswald

Completed

Effects of 500 mg Immediate Release and Extended Release Methylnaltrexone on Loperamide-induced Delay of the Oro-cecal and Whole-gut Transit Time in Healthy Subjects (LOP-MNTX-2009)

Intestinal Obstruction

Germany
Yale University

Completed

Naltrexone & SSRI in Alcoholics With Depression/PTSD

Depression | PTSD | Alcoholism

United States
Orexigen Therapeutics, Inc

Completed

A Safety and Efficacy Study Comparing Naltrexone SR/Bupropion SR and Placebo in Obese Subjects With Type 2 Diabetes

Obesity | Diabetes Mellitus, Type 2 | Overweight

United States
Orexigen Therapeutics, Inc

Terminated

Naltrexone SR and Fluoxetine Combination Therapy in Subjects With Obsessive-Compulsive Disorder

Obsessive-Compulsive Disorder

United States
University Rovira i Virgili

Recruiting

Dietary Strategy to Tackle Sarcopenia in Early Elderly Subjects (FOOP-Sarc) (FOOP-Sarc)

Sarcopenia

Spain
Sidney Kimmel Comprehensive Cancer Center at Johns...
Breast Cancer Research Foundation; American Institute for Cancer Research; Hopkins-WellSpan...

Active, not recruiting

Adaptive Nutrition and Exercise Weight Loss (A-NEW) Study (A-NEW)

Breast Cancer | Overweight or Obesity

United States
Pharmacotherapies for Alcohol and Substance Use...
Yale University; United States Department of Defense; VA Connecticut Healthcare... and other collaborators

Completed

Effect of Sublingual Formulation of Dexmedetomidine HCl (BXCL501) - Alcohol Interaction Study

Post Traumatic Stress Disorder (PTSD) | Alcohol Use Disorder (AUD)

United States
University of Nebraska

Completed

Assessment of and Treatment Applied to Food Addiction in a Rural Healthy Behaviors Clinic

Obesity

United States
Alkermes, Inc.

Completed

A Study of ALKS 3831 in Adults With Schizophrenia

Schizophrenia

United States, Bulgaria, Czechia
Johns Hopkins University

Completed

Effects of Hallucinogens and Other Drugs on Mood and Performance

Healthy

United States
AcelRx Pharmaceuticals, Inc.

Completed

Effect of Ketoconazole on Sufentanil NanoTab Pharmacokinetics

Pharmacokinetics

United States
Orexigen Therapeutics, Inc

Completed

Study to Evaluate the Effect of Naltrexone and Bupropion Extended-Release Combination on Cardiac Repolarization in Healthy Participants

Heart Repolarization

United States
National and Kapodistrian University of Athens
Athens Medical Center

Recruiting

Study of the Cardiometabolic Effects of Obesity Pharmacotherapy

Obesity | Blood Pressure

Greece
University of Arkansas
National Institute on Drug Abuse (NIDA)

Completed

Improving Treatment Outcomes for Prescription Opioid Dependence (GBN)

Drug Dependence

United States
Eli Lilly and Company

Completed

A Study of LY2216684 in Healthy Participants Receiving Albuterol or Propanolol

Major Depressive Disorder

United States
Purdue Pharma LP

Completed

The Effect of Buprenorphine Delivered by Buprenorphine Transdermal System (BTDS) at Doses up to 80 Micrograms/Hour (mcg/hr) and Naltrexone on Electrocardiogram (ECG) Intervals in Healthy Volunteers

ECG Effects

United States

Search clinical trials for: Alcoholic beverage

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Venezuela

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations